Sarepta Therapeutics (SRPT) Financial Analysis & Valuation | Quarter Chart

Sarepta Therapeutics (SRPT)

SRPT
Price: $16.67
Fair Value: 🔒
🔒score
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dyst... more
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery a... more
Description Shares
Market Cap$1.76BExchangeNASDAQ
SectorHealthcareIndustryBiotechnology
CountryUSCEODouglas S. Ingram
IPO Date1997-06-04CAGR0.4%
Employees1,372Websitewww.sarepta.com
Div. YieldPayout Ratio
Buy Back YieldTotal Yield
SRPT chart loading...
Fundamentals Technicals
Enterprise Value$2.86BP/E Ratio47.63
Forward P/E6.56PEG Ratio
P/S Ratio0.81P/B Ratio1.16
P/CF Ratio9.99P/FCF Ratio16.43
EPS$0.35EPS Growth 1Y
EPS Growth 3YEPS Growth 5Y
Revenue Growth 1Y-2.2%Gross Margin0.62%
Operating Margin-0.02%Profit Margin0.03%
ROE0.05%ROA0.02%
ROCE-0.02%Current Ratio4.63
Quick Ratio2.62Cash Ratio0.93
Debt/Equity0.69Interest Coverage-0.97
Altman Z Score0.09Piotroski Score8